U.S. Consumer Durables Stock News

ProPetro Holding Corp reported third quarter 2025 revenue of US$293.92 million, exceeding analyst forecasts despite an 18.6% year-over-year decline, and posted a reduced net loss of US$2 million with adjusted loss per share beating expectations. The company also announced its Propwr division secured a long-term hybrid energy contract with a major Midwest data center operator, marking a significant shift towards power generation services and expanding its role beyond traditional oilfield...

Formycon AG, Bioeq AG, and Teva Pharmaceutical Industries jointly announced the European launch of FYB201/Ranivisio® as the first Lucentis biosimilar available in an EMA-approved innovative pre-filled syringe presentation, marking a significant step in ophthalmic care standards. The introduction of a pre-filled syringe for ranibizumab biosimilar enhances convenience, safety, and dosing accuracy for ophthalmologists, while reinforcing Teva's commitment to biosimilar innovation. To assess the...

YPF and Globant recently announced the launch of Digital Suppl.AI, an agentic AI-powered transformation platform aimed at modernizing the supply chain of Argentina's top energy company, with initial developments targeting procurement and inventory management using Globant's AI Pods subscription model. This partnership highlights Globant's deep involvement in integrating AI-driven automation and real-time data utilization within critical operations, reflecting its commitment to driving...

Danaos (NYSE:DAC) just closed a $500 million senior notes offering at 6.875%. The company aims to pay down older, higher-interest debt and fund general corporate needs. This move should help streamline the company’s balance sheet and lower financing costs. See our latest analysis for Danaos. Over the past year, Danaos has steadily built momentum, with a 17% one-year total shareholder return that signals persistent value for long-term holders. While the share price has recently ticked up,...

In recent days, ARK Investment Management, led by Cathie Wood, acquired 1.03 million shares of Pacific Biosciences of California, highlighting renewed institutional interest despite previous insider selling and financial challenges. This move signals continued confidence in PacBio’s leadership in genomics innovation and may influence perceptions of the company’s long-term growth prospects among investors. We will explore how ARK’s substantial investment aligns with Pacific Biosciences’ focus...

BeOne Medicines (ONC) has been on the radar for investors after its stock showed both short-term dips and long-term gains. The company’s shares are up 71% year-to-date, despite recent month volatility. See our latest analysis for BeOne Medicines. BeOne Medicines’ share price has more than doubled so far this year, brushing off recent dips as momentum continues to build. While short-term moves have been mixed, the 71% year-to-date share price jump and a 53% total shareholder return over the...

DT Midstream, Inc. reported third-quarter 2025 net income of US$115 million, or US$1.13 per diluted share, surpassing analyst estimates and announcing higher full-year Adjusted EBITDA guidance following the successful expansion of key pipeline projects. The company's early, on-budget commissioning of the LEAP Phase 4 project and upsized Guardian Pipeline expansion highlight its focus on accelerating infrastructure development and responding to growing energy demand. Given the increased...

Wondering whether Automatic Data Processing is priced just right or if there might be a hidden value waiting to be discovered? You are not alone. Many investors are taking a closer look at the stock these days. After some impressive long-term growth, ADP’s share price has dipped recently, sliding 8.0% over the past week and 10.7% for the month. This puts year-to-date returns at -9.8%. Market chatter has picked up around Automatic Data Processing in light of broader tech...

United Therapeutics (UTHR) stock has been on the move lately, prompting many to take a closer look at what is driving this performance. The company has posted solid returns over the past month, which has sparked fresh interest among investors. See our latest analysis for United Therapeutics. United Therapeutics’ share price has surged 66% over the past three months, with short-term momentum picking up quickly and one-year total shareholder return reaching nearly 26%. Recent enthusiasm around...

Earlier this week, Ardelyx, Inc. presented new clinical and real-world data for IBSRELA® (tenapanor) at the American College of Gastroenterology’s Annual Scientific Meeting in Phoenix, emphasizing its efficacy for adults with irritable bowel syndrome with constipation (IBS-C). These findings not only highlight high patient satisfaction and meaningful improvements in IBS-C symptoms, but also indicate a potential reduction in healthcare resource utilization following IBSRELA initiation. We'll...

The Vita Coco Company, Inc. recently reported third quarter 2025 results, highlighting a 37% year-on-year increase in net sales to US$182.31 million, alongside raised full-year guidance for both net sales and adjusted EBITDA driven by strong coconut water demand and the introduction of Vita Coco Treats in the U.S. A significant insight from the announcement is Vita Coco's ability to offset higher tariffs and finished goods costs with effective pricing and lower logistics expenses, while...

Beyond Meat (BYND) shares continue to remain under pressure, recently trading at $1.85. Investors have seen the stock decline further this year. This has prompted a closer look at whether the current valuation reflects ongoing performance challenges. See our latest analysis for Beyond Meat. Beyond Meat's share price has dropped more than 48% over the past week, adding to a year-to-date loss of 52%. This sharp slide reflects fading momentum and persistent doubts about the company's growth...

Airbus recently announced a reduction in its A220 aircraft production target for next year, lowering projections from 14 to 12 planes per month due to continued supply-chain challenges. This shift has important implications for key suppliers like Spirit AeroSystems, which relies on Airbus’s A220 program as a significant source of revenue. We'll explore how Airbus’s A220 production cut, stemming from supply-chain issues, shapes Spirit AeroSystems' current investment narrative. We've found 21...

Curious if Goldman Sachs Group is still a good buy after its strong run? You're not alone. Taking a closer look at its value could be important for your next move. The stock has surged 52.4% over the past year and jumped 5.2% in just the last week. However, it dipped slightly by 2.6% over the last month, which has left investors watching for its next direction. Shares have been supported by recent leadership changes and increasing optimism about the banking sector's resilience. News of...

Equinix, Inc. reported strong third quarter results, announced a new quarterly dividend of US$4.69 per share, and confirmed plans for a £4 billion UK data center investment, with the dividend scheduled for payment on December 17, 2025 to shareholders of record as of November 19, 2025. The company’s substantial capacity expansion and progress in AI and interconnection services continue to highlight its focus on supporting digital infrastructure growth worldwide. We'll explore how Equinix’s...

CommScope Holding Company reported third quarter and nine-month 2025 earnings, revealing sales of US$1.63 billion and US$4.13 billion, respectively, with a shift from net losses to net profits compared to the prior year. The company’s improved profitability and stronger earnings metrics, including a move from negative to positive earnings per share, highlight a clear turnaround in business performance compared to the same periods last year. We'll examine how CommScope’s return to quarterly...

Cactus (WHD) released its third quarter 2025 earnings, reporting a decline in both sales and net income from continuing operations compared to last year. This earnings update is drawing attention from investors. See our latest analysis for Cactus. Shares of Cactus responded sharply to the earnings report, with a 7.3% jump on the day and a 12.1% share price return over the past week. This signals renewed momentum despite softer sales and profit figures. While 2025 has been challenging, with a...

Eyeing Advanced Micro Devices and wondering if its recent gains mean the stock is a bargain or frothy? Take a closer look at what is driving the excitement and how valuation measures up. AMD’s share price has surged lately, jumping 14.8% in the past week and a massive 63.8% over the last month, on top of an impressive 119.1% year-to-date gain. These swings are turning heads, suggesting momentum and shifting expectations about its future. Recent headlines have highlighted...

PG&E (PCG) stock has experienced some movement over the past month, catching the interest of investors who track utility sector trends. Shares are up 5% in the past month, even though the year-to-date return has been softer. See our latest analysis for PG&E. Despite a recent pullback, with a one-day share price return of -2.23% and a 7-day drop of nearly 5%, PG&E’s shares have climbed 4.65% over the past month. However, the year-to-date share price return sits firmly in the red. In a broader...

Applied Optoelectronics (AAOI) is ramping up its U.S. presence with a $150 million investment to expand manufacturing in Sugar Land, Texas. This includes a major facility focused on AI data center technology. See our latest analysis for Applied Optoelectronics. Shares of Applied Optoelectronics have shown remarkable momentum lately, with a 36.78% share price return over the past month and a 55.14% gain in the past 90 days. Investors appear to be responding positively to recent U.S. expansion...

EMCOR Group (NYSE:EME) just raised its full-year 2025 revenue guidance, now expecting between $16.7 billion and $16.8 billion compared to a previous range of $16.4 billion to $16.9 billion. This signals management’s increased confidence in future growth. See our latest analysis for EMCOR Group. This stronger revenue outlook comes as EMCOR’s shares have delivered an impressive 21.3% gain over the past month, building on momentum from robust results and fresh board appointments. Over the last...

In the third quarter of 2025, Vicor Corporation reported revenue of US$110.42 million and net income of US$28.29 million, up significantly from the same period last year, and completed a share buyback totaling 747,124 shares for US$33.82 million under its ongoing program. An interesting development is that much of Vicor’s exceptionally strong performance was driven by substantial intellectual property licensing revenues, with management highlighting potential for further growth in this...

Fortive (FTV) shares have shown a modest lift over the past week, offering investors a fresh reason to look at the stock’s performance in a broader context. The company’s returns over the past month and three months point to steady upward momentum. See our latest analysis for Fortive. The recent lift in Fortive’s share price comes after a long stretch of more muted performance and a year-to-date decline of over 32%. Still, longer-term investors have seen positive momentum, with a five-year...

Summit Therapeutics (SMMT) shares have caught extra attention after releasing encouraging Phase III trial results for its lead therapy, ivonescimab. The drug outperformed established lung cancer treatments, fueling optimism about upcoming regulatory milestones and future sales. See our latest analysis for Summit Therapeutics. After Summit’s breakthrough Phase III results, momentum around the stock remains strong despite some near-term share price volatility. A string of recent events,...